ストックスクリーナーアプリを入手
96.97
1.38%
-1.19
Gilead Sciences Inc (GILD) 最新ニュース
Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités - GlobeNewswire Inc.
Earth Day Focus for Gilead Sciences – Every Action Has an Impact - CSRwire
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight - GuruFocus
Gilead Sciences Holds Annual Stockholders Meeting - TipRanks
Gilead Joins Pharma’s US Investment Rush - insights.citeline.com
Gilead Sciences holds annual stockholders meeting - Investing.com
Gilead reports final outcomes from trial of bulevirtide for chronic HDV - Clinical Trials Arena
Drugmaker Gilead pledges $11 billion investment in U.S. manufacturing - The Business Journals
Gilead Sciences Increases Investment in U.S. Operations - Contract Pharma
Earth Day Focus for Gilead SciencesEvery Action Has an Impact - ACCESS Newswire
Gilead ups its US investment plans by $11 billion - Pharmaphorum
Gilead Pumps $11B More Into US Manufacturing, Hopes To Add 3,000 Jobs - BioSpace
Gilead tees up $11B in new US manufacturing, R&D investments - Fierce Pharma
Gilead to invest $32 billion in US manufacturing and R&D - The Pharma Letter
How To Put $100 In Your Retirement Fund Each Month With Gilead Sciences Stock - Yahoo Finance
Gilead announces $11 billion in new investments in US - msn.com
Gilead is latest to pledge allegiance to America with $32B manufacturing commitment - FirstWord Pharma
Gilead boosts planned US investments by $11 billion amid tariff threat - msn.com
Gilead (GILD) to Boost U.S. Operations with $11 Billion Investment | GILD Stock News - GuruFocus
Gilead Sciences (GILD) Boosts U.S. Investment by $11 Billion - GuruFocus
Gilead Sciences Announces $11 Billion U.S. Investment BoostNews and Statistics - IndexBox
Gilead to invest $32B in U.S.through 2030 (GILD:NASDAQ) - Seeking Alpha
Gilead Sciences to invest $11 billion in U.S. R&D and manufacturing By Investing.com - Investing.com
Gilead announces $11 billion in new investments in US By Reuters - Investing.com
Gilead Sciences (GILD) U.S. Investment to Create $43B in Value to U.S. Economy - StreetInsider
Gilead Boosts Planned US Investments by $11 Billion Amid Tariff Threat - US News Money
Gilead To Invest $32 Bln In U.S. Manufacturing And R&D Through 2030 - marketscreener.com
Gilead Sciences (NasdaqGS:GILD) Presents Promising Data On Livdelzi And Bulevirtide At EASL 2025 - simplywall.st
Fighting the World’s Most Devastating Diseases Is the Focus of This Installment of “The Centrifuge Sessions - CSRwire
Gilead’s Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025 - BioSpace
Gilead (GILD): Livdelzi Shows Promising Results for PBC Treatment | GILD Stock News - GuruFocus
GILD: Promising Results from Gilead's Bulevirtide Study for Chronic Hepatitis Delta | GILD Stock News - GuruFocus
Gilead to Invest $11 Billion to Bolster Domestic Operations - WSJ
Gilead's Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy - GuruFocus
Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment - Business Wire
Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Gilead (GILD) Sees Bearish Options Activity with Heavy Put Trading | GILD Stock News - GuruFocus
Fighting the World's Most Devastating Diseases Is the Focus of This Installment of "The Centrifuge Sessions" - marketscreener.com
Gilead: Sure, Why Not, But Not The CDRs (GILD:CA) - Seeking Alpha
What Are Wall Street Analysts' Target Price for Gilead Sciences Stock? - Nasdaq
Mizuho Adjusts Price Target on Gilead Sciences to $117 From $100, Maintains Outperform Rating - marketscreener.com
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term - Yahoo
What Are Wall Street Analysts' Target Price For Gilead Sciences Stock? - Barchart.com
Gilead (GILD) Sees 24% Stock Surge Amid Tariff Resilience - GuruFocus
Gilead and Vertex Pharma named among biotech’s tariff safe havens - MSN
Press Release Distribution & PR Platform - ACCESS Newswire
Here's What to Expect From Gilead Sciences’ Next Earnings Report - MSN
Struggling Peninsula biotech with Gilead lineage is latest purchase for activist investor - The Business Journals
Gilead Sciences (GILD): A Promising Pick Amid Economic Uncertain - GuruFocus
June 13th Options Now Available For Gilead Sciences (GILD) - Nasdaq
Gilead Agrees To Pay $202M To Settle Alleged Speaker Kickback Claims In FCA Suit - Law360
0.27%
大文字化:
|
ボリューム (24 時間):